SCHEMBL24512716

SCHEMBL24512716

O=Cc1ccnc(Oc2ccc(F)cc2)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 3/20 0.51
▸ MAPT P10636 2/20 0.51
▸ ALDH1A1 P00352 3/20 0.47
▸ KDM4E B2RXH2 1/20 0.47
▸ LMNA P02545 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ RAB9A P51151 1/20 0.41
▸ MAPK14 Q16539 2/20 0.40
▸ SCN9A Q15858 2/20 0.40
▸ KCNH2 Q12809 1/20 0.38
▸ SCN5A Q14524 1/20 0.38
▸ CYP1A2 P05177 3/20 0.38
▸ CYP2C19 P33261 3/20 0.38
▸ TRPA1 O75762 2/20 0.38
▸ CYP3A4 P08684 2/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ KMT2A Q03164 3/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24512696 0.75 ALDH1A1 (0.46) L3MBTL1MAPTALDH1A1KDM4ELMNA
SCHEMBL1415792 0.75 L3MBTL1 (0.63) L3MBTL1MAPTALDH1A1KDM4ESMN1; SMN2
SCHEMBL6943230 0.73 MEN1 (0.63) L3MBTL1MAPTALDH1A1KDM4ELMNA
SCHEMBL10708134 0.72 L3MBTL1 (0.50) L3MBTL1MAPTALDH1A1KDM4EMAPK14
SCHEMBL31129055 0.72 POLB (0.40) L3MBTL1ALDH1A1KDM4ELMNAMAPK14
SCHEMBL4976296 0.72 ALDH1A1 (0.39) MAPTALDH1A1KDM4ELMNASMN1; SMN2
SCHEMBL16838775 0.71 L3MBTL1 (0.53) L3MBTL1ALDH1A1KDM4ELMNASMN1; SMN2
SCHEMBL21901753 0.71 ALDH1A1 (0.66) L3MBTL1MAPTALDH1A1KDM4ELMNA
SCHEMBL20524290 0.70 MEN1 (0.58) L3MBTL1MAPTALDH1A1KDM4ESCN9A
SCHEMBL24512733 0.70 MAPT (0.47) L3MBTL1MAPTSMN1; SMN2RAB9ASCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220185815-A1 PYRROLOPYRAZOLE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2022-06-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220185815-A1 PYRROLOPYRAZOLE DERIVATIVE PTDSS1, PTDSS2, SMPD1 L3MBTL1 3807/4885MAPT 4781/4885ALDH1A1 2761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback